Uncategorized
Glaukos Announces Five-Year Extensions for Three Category III CPT Codes Related to Micro-Invasive Glaucoma Surgery
SAN CLEMENTE, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma, today announced that the Current Procedural Terminology (CPT) Editorial Panel of the American Medical Association has granted five-year extensions to three Category III CPT codes that describe insertion of aqueous drainage devices into the anterio